
Bayer/Monsanto: Glyphosate Ruling in the US Sends a Strong Signal
Monsanto wins the first glyphosate case unanimously following the landmark decision by the US Supreme Court in June.

Monsanto wins the first glyphosate case unanimously following the landmark decision by the US Supreme Court in June.

Bayer has seen its share of turbulent shareholder meetings, and the event on Apr. 28 is likely to continue in that vein, though it would be tough to top 2019. In that year, when anger over lawsuits involving Monsanto’s Roundup herbicide boiled over, 55% voted not to discharge CEO Werner Baumann and the managing board of their responsibilities.

The European Commission has provisionally renewed the license of the herbicide active ingredient glyphosate until the end of 2023. Earlier this year, the EU governing body had asked all member states to approve a one-year extension.

Bayer has backed away from plans to create a science advisory panel to help decide still outstanding claims from US plaintiffs that Monsanto’s glyphosate-based herbicide Roundup caused their non-Hodgkins lymphoma.

Bayer’s relief over its recent deal to settle three-quarters of its outstanding Roundup-related US lawsuits for more than $10 billion altogether could be short-lived.











